To identify novel bioactive compounds, the methanolic leaf extract of Stevia rebaudiana was investigated for its antibacterial and selective cytotoxic activities using integrated in vitro and in silico approaches. Antibacterial and cytotoxic activities were evaluated using agar well diffusion and MTT assays, respectively. S. rebaudiana phytochemicals were evaluated by docking, ADMET/toxicity prediction, 100 ns MD simulations, and MM/PBSA analysis. The methanolic extract exhibited concentration‐dependent antibacterial activity, with the highest inhibition zone observed against S. rubidaea (22.1 ± 0.13 mm at 150 µg/mL). The extract also showed selective cytotoxicity toward HeLa cells (IC 50 ≈ 7.1 mg/mL), whereas Vero cells retained more than 85% viability at the highest tested concentration. Molecular docking identified glutinol acetate and octamethyl picen‐3‐ol as the most favorable phytochemicals. MD simulations revealed complex stability, and MM/PBSA revealed favorable binding with glutinol acetate exhibiting the strongest binding energy (ΔG_bind ‐24.11 kcal/mol) for its binding to Bcl‐2. ADMET and toxicity analyses revealed some drug‐likeness and toxicity concerns, justifying experimental validation. Overall, methanolic S. rebaudiana leaf extract showed antibacterial activity and preferential cytotoxicity against HeLa cells. The predicted interactions with selected protein targets were favorable for glutinol acetate and octamethyl picen‐3‐ol, and they should be further investigated.